0001014739-21-000051.txt : 20210922 0001014739-21-000051.hdr.sgml : 20210922 20210922172011 ACCESSION NUMBER: 0001014739-21-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210917 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210922 DATE AS OF CHANGE: 20210922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Option Care Health, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11993 FILM NUMBER: 211270311 BUSINESS ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 BUSINESS PHONE: 312 940 2443 MAIL ADDRESS: STREET 1: 3000 LAKESIDE DR STREET 2: SUITE 300N CITY: BANNOCKBURN STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BioScrip, Inc. DATE OF NAME CHANGE: 20050314 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 8-K 1 bios-20210917.htm 8-K bios-20210917
FALSE000101473900010147392021-08-112021-08-11

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
September 17, 2021
 _____________________
OPTION CARE HEALTH, INC.
(Exact name of registrant as specified in its charter)
_____________________
Delaware
001-11993
05-0489664
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
3000 Lakeside Dr. Suite 300N, Bannockburn, IL 60015
(Address of principal executive offices)
 
(312) 940-2443
(Registrant's telephone number, including area code)
_____________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

  Securities registered pursuant to Section 12(b) of the Act:
Title of each ClassTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0001 par value per shareOPCHNasdaq Global Select Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ¨


 




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On September 17, 2021, Clifford Berman, Senior Vice President, General Counsel and Corporate Secretary of Option Care Health, Inc. (the “Company”), notified the Company that he intends to retire on March 31, 2022.

Mr. Berman, age 62, will continue in his current duties through the end of March, 2022, while the Company engages an executive search firm to identify his successor. Mr. Berman has been a member of the Company’s executive leadership team for six years and has been instrumental in the Company’s success after separating from Walgreens in April 2015. Mr. Berman will retire following a 39-year career, starting as a pharmacist with Walgreens and subsequently as legal counsel at several leading health care companies, including Baxter, Caremark, Allscripts, Abbott Laboratories, and Catamaran.

































   



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Option Care Health, Inc.
Date:September 22, 2021By:/s/ Michael Shapiro
Name:Michael Shapiro
Title:Chief Financial Officer

EX-101.SCH 2 bios-20210917.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 bios-20210917_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line Two Entity Address, Address Line Two Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 4 bios-20210917_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 bios-20210917_htm.xml IDEA: XBRL DOCUMENT 0001014739 2021-08-11 2021-08-11 false 0001014739 8-K 2021-09-17 OPTION CARE HEALTH, INC. DE 001-11993 05-0489664 3000 Lakeside Dr. Suite 300N Bannockburn IL 60015 312 940-2443 false false false false Common Stock, $0.0001 par value per share OPCH NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Aug. 11, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 17, 2021
Entity Registrant Name OPTION CARE HEALTH, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-11993
Entity Tax Identification Number 05-0489664
Entity Address, Address Line One 3000 Lakeside Dr.
Entity Address, Address Line Two Suite 300N
Entity Address, City or Town Bannockburn
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60015
City Area Code 312
Local Phone Number 940-2443
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol OPCH
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001014739
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.bioscrip.com/role/Cover Cover Cover 1 false false All Reports Book All Reports bios-20210917.htm bios-20210917.xsd bios-20210917_lab.xml bios-20210917_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bios-20210917.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "bios-20210917.htm" ] }, "labelLink": { "local": [ "bios-20210917_lab.xml" ] }, "presentationLink": { "local": [ "bios-20210917_pre.xml" ] }, "schema": { "local": [ "bios-20210917.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bios", "nsuri": "http://www.bioscrip.com/20210917", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bios-20210917.htm", "contextRef": "if62e09050fa34fa8b611c54f058687ed_D20210811-20210811", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.bioscrip.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bios-20210917.htm", "contextRef": "if62e09050fa34fa8b611c54f058687ed_D20210811-20210811", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.bioscrip.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001014739-21-000051-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001014739-21-000051-xbrl.zip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end